Opioids are the main drug group implicated in drug overdose deaths in Ireland. Naloxone is an antidote for opioid overdose that reverses the depressant effects of opioids such as heroin. Following a successful pilot of the Naloxone Demonstration Project in 2015, the Health Service Executive (HSE) developed a naloxone training programme for service providers. However, there has been little evaluation of the expanded naloxone programme since its initial pilot phase. A 2022 report aimed to provide an assessment of the impact of the provision of naloxone and training to addiction and homeless service providers in Ireland. This article highlights the main findings.

The annual report for 2021 for Coolmine was launched on 15 November 2022. The launch was held in Ashleigh House, Dublin, which is Coolmine’s residential service for women and children. Ashleigh House is part of a suite of addiction services provided by the organisation, offering community and day services, as well as residential services for women and their children, and men. Services are delivered across 13 facilities, including those in the Mid-West and South West, which were established in 2021.